Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$10,369 Mln
Revenue (TTM)
$154,580 Mln
Net Profit (TTM)
$0 Mln
ROE
-0.7 %
ROCE
-17.8 %
P/E Ratio
--
P/B Ratio
1.4
Industry P/E
19.88
EV/EBITDA
-22.6
Div. Yield
4.2 %
Debt to Equity
1
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
865,561,024
CFO
$55,710.00 Mln
EBITDA
$55,531.00 Mln
Net Profit
$26,450.00 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Walgreens Boots Alliance (WBA)
| 28.4 | 3.2 | 6.9 | 26.8 | -30.7 | -21.2 | -18.1 |
|
BSE Sensex*
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Midcap 400#
| 1.8 | -4.7 | 3.1 | 16.1 | 10.7 | 5.2 | 8.9 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Walgreens Boots Alliance (WBA)
| -64.0 | -30.1 | -28.4 | 30.8 | -32.4 | -13.7 | -5.9 |
|
S&P Midcap 400
| 12.1 | 14.4 | -14.5 | 23.2 | 11.8 | 24.1 | -12.4 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S.... Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois. Read more
Executive Chairman of the Board
Mr. Stefano Pessina
Executive Chairman of the Board
Mr. Stefano Pessina
Headquarters
Deerfield, IL
Website
The share price of Walgreens Boots Alliance Inc (WBA) is $11.98 (NASDAQ) as of 28-Aug-2025 09:30 EDT. Walgreens Boots Alliance Inc (WBA) has given a return of -30.7% in the last 3 years.
Since, TTM earnings of Walgreens Boots Alliance Inc (WBA) is negative, P/E ratio is not available.
The P/B ratio of Walgreens Boots Alliance Inc (WBA) is 1.44 times as on 28-Aug-2025, a 61 discount to its peers’ median range of 3.68 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
--
|
--
|
|
2023
|
--
|
--
|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
The 52-week high and low of Walgreens Boots Alliance Inc (WBA) are Rs 13.25 and Rs 8.08 as of 04-Apr-2026.
Walgreens Boots Alliance Inc (WBA) has a market capitalisation of $ 10,369 Mln as on 28-Aug-2025. As per SEBI classification, it is a Mid Cap company.
Before investing in Walgreens Boots Alliance Inc (WBA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.